Dan Teleman
Amministratore Delegato presso Pharma Two B Ltd.
Profilo
Dan Teleman was the founder of PainReform Ltd.
(founded in 2007) and previously held the position of Chief Executive Officer at Pharma Two B Ltd.
He previously served as Chief Executive Officer at Atox Bio Ltd.
and held the position of Chairman at Tamarix Pharma Ltd.
from 2021 to 2023.
Mr. Teleman also has experience as Head-Marketing & Sales at Amgen, Inc. and as a Senior Business Development Officer at W World Corp.
He has a background in the Israel Defense Forces, where he served as a Principal.
Additionally, Mr. Teleman was an Executive Partner at Israel Biotech Fund from 2022 to 2023.
He completed his graduate studies at Ben-Gurion University of the Negev and holds an MBA from The Fuqua School of Business.
Posizioni attive di Dan Teleman
| Società | Posizione | Inizio |
|---|---|---|
Pharma Two B Ltd.
 Pharma Two B Ltd. Pharmaceuticals: GenericHealth Technology Pharma Two B Ltd. operates as a biopharmaceutical company which focuses on developing treatments for Parkinson’s disease. The firm focuses on Fixed-Dose-combinations of two or more drugs with synergistic effects, providing clinical value and regulatory pathways. The company was founded by Ehud Marom and Nurit Livnah in December 2007 and is headquartered in Rehovot, Israel. | Amministratore Delegato | 01/05/2023 |
Precedenti posizioni note di Dan Teleman
| Società | Posizione | Fine |
|---|---|---|
Israel Biotech Fund
 Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Investitore di Private Equity | 01/05/2023 |
Tamarix Pharma Ltd
 Tamarix Pharma Ltd Pharmaceuticals: MajorHealth Technology Tamarix Pharma Ltd develops a novel small compounds for reducing excessive apoptosis. The company is based in Rehovot, Israel. The CEO of the Israeli company is Isaac Tal. | Presidente | 01/05/2023 |
| Israel Defense Forces | Corporate Officer/Principal | - |
Atox Bio Ltd.
 Atox Bio Ltd. BiotechnologyHealth Technology Atox Bio, Inc. provides novel immune modulators for critically ill patients with severe infections. The firm discovers and develops novel immune modulators for critically ill patients with severe infections. Its main product is AB103, a novel immune modulator. The company was founded by Raymond Kaempfer and Gila Arad in 2003 and is headquartered in Ness Ziona, Israel. | Amministratore Delegato | - |
| AMGEN INC. | Corporate Officer/Principal | - |
Formazione di Dan Teleman
| Ben-Gurion University of the Negev | Graduate Degree |
| The Fuqua School of Business | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| PAINREFORM LTD. | Health Technology |
| W WORL | Health Technology |
| AMGEN INC. | Health Technology |
| Aziende private | 5 |
|---|---|
Atox Bio Ltd.
Atox Bio Ltd. BiotechnologyHealth Technology Atox Bio, Inc. provides novel immune modulators for critically ill patients with severe infections. The firm discovers and develops novel immune modulators for critically ill patients with severe infections. Its main product is AB103, a novel immune modulator. The company was founded by Raymond Kaempfer and Gila Arad in 2003 and is headquartered in Ness Ziona, Israel. | Health Technology |
| Israel Defense Forces | Government |
Tamarix Pharma Ltd
Tamarix Pharma Ltd Pharmaceuticals: MajorHealth Technology Tamarix Pharma Ltd develops a novel small compounds for reducing excessive apoptosis. The company is based in Rehovot, Israel. The CEO of the Israeli company is Isaac Tal. | Health Technology |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Finance |
Pharma Two B Ltd.
Pharma Two B Ltd. Pharmaceuticals: GenericHealth Technology Pharma Two B Ltd. operates as a biopharmaceutical company which focuses on developing treatments for Parkinson’s disease. The firm focuses on Fixed-Dose-combinations of two or more drugs with synergistic effects, providing clinical value and regulatory pathways. The company was founded by Ehud Marom and Nurit Livnah in December 2007 and is headquartered in Rehovot, Israel. | Health Technology |
- Borsa valori
- Insiders
- Dan Teleman
